Related Experiment Video

Updated: Mar 8, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

28.0K

Prevention and Therapy of Pediatric Emergence Delirium: A National Survey

Christopher Huett1, Torsten Baehner1, Felix Erdfelder1

  • 1Department of Anesthesiology and Intensive Care, Bonn University Hospital, Sigmund Freud Str. 25, 53105, Bonn, Germany.

Paediatric Drugs
|January 29, 2017
PubMed

Insights

Propofol is the preferred choice for preventing and treating pediatric emergence delirium (ED) among German anesthesiologists. Current practices show underrepresentation of alternative therapies and midazolam-centered premedication strategies.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Pediatric emergence delirium (ED) is a common yet controversial issue regarding its pharmacological prevention and treatment.
  • Existing evidence on various treatment options for ED is often limited and inconclusive.

Purpose of the Study:

  • To investigate current clinical practices in the prevention and treatment of pediatric ED.
  • To understand the routine management strategies employed by anesthesiologists in Germany.

Main Methods:

  • A web-based survey was distributed to members of the German Society of Anesthesiology.
  • The survey collected data on ED management, facility structure, and patient demographics.

Main Results:

  • 88% of respondents consider ED a significant clinical problem, but only 5% use formal assessment scores.
  • Oral midazolam is the standard premedication for 84% of respondents.
  • Total intravenous propofol anesthesia is the primary prevention strategy (63%).
  • Experienced anesthesiologists favor propofol for ED treatment, while less experienced ones prefer opioids.
  • Propofol received the highest satisfaction ratings for ED treatment.

Conclusions:

  • Propofol is the leading choice for pharmacological prevention and treatment of ED in German pediatric anesthesia.
  • Alternative therapeutic options and non-midazolam premedication strategies are currently underutilized.
Abstract

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:20

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

652
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
95
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646